(S)-4-Ethyl-4-hydroxy-1H-pyrano[3,4-c]pyridine-3,8(4H,7H)-dione, 95+%, 250mg

6-Bromo-2-chloroquinoxaline, 95.0%, 1g

N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine>98.0%(HPLC)(T)25g

3-cyclopropyl-5-nitro-1H-pyrazole, 1g

7,8-Dimethoxy-1H-benzo[d]azepin-2(3H)-one>98.0%(GC)1g

4-[2-(TRIFLUOROMETHYL)PHENOXY]PIPERIDINE HCL, 95.0%, 250mg

(4-Bromo-3-methoxyphenyl)methanamine hydrochloride, 95+%, 1g

(2-Amino-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl)-p-tolyl-methanone, 50mg

(S)-4-(3-Bromophenyl)-3-((tert-butoxycarbonyl)amino)butanoic acid, 98%, 250mg

4'-Methoxy-2'-methylacetophenone, 97.0%, 5g

2-amino-5-(benzyloxy)-3,4-dihydropyrimidin-4-one, 95%, 1g

4-Phenyl-2H-1,2,4-benzothiadiazin-3(4H)-one-1,1-dioxide sodium salt, 1g

3,3-Dimethyl-N-(piperidine-4-yl)butanamido hydrochloride, 95.0%, 1g